Refsum’s disease: clinical features
Evidence-based neurology checklist on refsum’s disease: clinical features: Genetics and pathology This is a peroxisomal disorder It is caused by mutations in the PHYH and PEX7 genes The mutation causes elevation of plasma phytanic acid levels This leads to phytanic acid accumulation in tissues:…
Genetics and pathology
- This is a peroxisomal disorder
- It is caused by mutations in the PHYH and PEX7 genes
- The mutation causes elevation of plasma phytanic acid levels
- This leads to phytanic acid accumulation in tissues: nerves, brain, and fat
- Pristanic acid levels are reduced
Tapetoretinal degeneration: features
Other ophthalmic features
Skeletal malformations
Neurological features
Systemic features
Triggers for deterioration
Clinical differentials
Differentials of raised phytanic acid
References
- Ruether K, Baldwin E, Casteels M, et al. Adult Refsum's disease: a form of taporetinal dystrophy accessible to therapy. Surv Ophthalmol 2010; 55:531-538.
- Jayaram H, Downes SM. Midlife diagnosis of Refsum's disease in siblings with retinitis pigmentosa-the footprint is the clue: a case report. J Med Case Reports 2008; 2:80.
- Embiruçu EK, Martyn ML, Schlesinger D, Kok F. Autosomal recessive ataxias: 20 types, and counting. Arq Neuropsiquiatr 2009; 67:1143-1156.
- Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol 2007; 6:245-257.
- Poll-The BT, Gärtner J. Clinical diagnosis, biochemical findings and MRI spectrum of peroxisomal disorders. Biochim Biophys Acta 2012; 1822:1421-1429.
- And 2 more. Subscribe to see the full list
